- Home
- AUTL vs NRC Comparison
AUTL vs NRC Comparison
Compare AUTL & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | NRC |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 428.2M |
| IPO Year | 2025 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AUTL | NRC |
|---|---|---|
| Price | $1.41 | $17.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 102.3K |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.69% |
| EPS Growth | 28.33 | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | $10,120,000.00 | ★ $119,686,000.00 |
| Revenue This Year | $669.62 | N/A |
| Revenue Next Year | $79.78 | N/A |
| P/E Ratio | ★ N/A | $0.35 |
| Revenue Growth | ★ 496.00 | 1.81 |
| 52 Week Low | $1.11 | $9.76 |
| 52 Week High | $2.70 | $22.79 |
Technical Indicators
Market Signals| Indicator | AUTL | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 63.68 |
| Support Level | $1.27 | $14.78 |
| Resistance Level | $1.52 | $18.27 |
| Average True Range (ATR) | 0.08 | 1.01 |
| MACD | -0.02 | 0.42 |
| Stochastic Oscillator | 14.29 | 88.99 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.